Incyte nears $2B deal for blood disorder biotech Star Therapeutics
Incyte is close to acquiring Star Therapeutics for up to $2 billion, aiming to strengthen its drug pipeline in the blood disorder space.
Incyte is close to acquiring Star Therapeutics for up to $2 billion, aiming to strengthen its drug pipeline in the blood disorder space.
OPEC+ agreed to a modest oil quota increase for July, signaling continued production management despite logistical challenges.
OpenAI is reportedly preparing a significant strategic shift towards a 'superapp' model and a major ChatGPT update to enhance its market position before a potential IPO.
BPM proposes €50bn merger with Monte dei Paschi, aiming for banking consolidation.
Sellers in a hot housing market offer homes for AI stock, but tech company boards must approve such deals.
Google innovates data center construction, while others explore solar hacks, AI for teens, and Siri's AI revival.
CEOs and Microsoft reveal AI's high costs and low returns, challenging investor optimism.
Investors eye Oracle, Adobe, and FuelCell Energy earnings for market direction this week.
New wearable trackers face off in a head-to-head test of sleep and heart rate accuracy.
McDonald's is piloting Archy IQ, an AI system from Google, in its drive-thrus to boost order accuracy and speed, with potential for a national rollout.
SpaceX's massive valuation requires 60x growth in a decade, a target no company has ever achieved, leaving little room for error.
Billionaires leverage mortgages for savvy financial gains on luxury real estate.